'Catalytic' doses of fructose may benefit glycaemic control without harming cardiometabolic risk factors: a small meta-analysis of randomised controlled feeding trials (Q24624267)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | 'Catalytic' doses of fructose may benefit glycaemic control without harming cardiometabolic risk factors: a small meta-analysis of randomised controlled feeding trials |
scientific article |
Statements
'Catalytic' doses of fructose may benefit glycaemic control without harming cardiometabolic risk factors: a small meta-analysis of randomised controlled feeding trials (English)
0 references
Marco Di Buono
1 reference
August 2012
0 references
1 August 2012
2 references
18 November 2019
19 July 2022
2 references
18 November 2019
19 July 2022
108
0 references
418-23
0 references
3
0 references
2 references
18 November 2019
19 July 2022
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference